Julian Leathart

5.0k total citations · 3 hit papers
37 papers, 3.7k citations indexed

About

Julian Leathart is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Julian Leathart has authored 37 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Julian Leathart's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Julian Leathart is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Julian Leathart collaborates with scholars based in United Kingdom, Italy and Australia. Julian Leathart's co-authors include Ann K. Daly, Christopher P. Day, Guruprasad P. Aithal, Quentin M. Anstee, Helen L. Reeves, Alastair D. Burt, David L. Gally, A.-C. Piguet, Jean‐François Dufour and Gillian Patman and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Blood.

In The Last Decade

Julian Leathart

37 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial of Genotype-Guided Dosing of Warfarin

2013 590 citations Julian Leathart, Hugo Kohnke et al. profile →
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

2014 454 citations Helen L. Reeves, Alastair D. Burt et al. profile →
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma

2014 404 citations Liu Yl, Gillian Patman et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julian Leathart United Kingdom	26	1.6k	1.4k	901	699	612	37	3.7k
Naga Chalasani United States	28	3.3k 2.1×	846 0.6×	1.0k 1.1×	861 1.2×	731 1.2×	69	5.1k
Adrian Reuben United States	38	2.0k 1.3×	976 0.7×	360 0.4×	793 1.1×	601 1.0×	140	4.6k
Kurt Einarsson Sweden	49	1.6k 1.0×	1.0k 0.8×	1.4k 1.5×	3.2k 4.5×	1.6k 2.7×	224	7.6k
Rommel G. Tirona Canada	39	713 0.5×	2.0k 1.4×	612 0.7×	3.1k 4.4×	1.1k 1.8×	99	5.7k
Nicola Carulli Italy	34	2.1k 1.3×	205 0.1×	805 0.9×	840 1.2×	618 1.0×	115	4.1k
Lars P. Bechmann Germany	28	1.9k 1.2×	373 0.3×	466 0.5×	270 0.4×	721 1.2×	79	3.2k
Norberto C. Chávez‐Tapia Mexico	36	2.9k 1.8×	322 0.2×	912 1.0×	348 0.5×	703 1.1×	194	4.7k
R. Todd Stravitz United States	36	2.1k 1.4×	968 0.7×	375 0.4×	939 1.3×	683 1.1×	59	4.3k
Harshad Devarbhavi India	24	2.6k 1.7×	1.4k 1.0×	280 0.3×	585 0.8×	935 1.5×	84	5.5k
Shivakumar Chitturi Australia	25	4.4k 2.8×	392 0.3×	2.1k 2.4×	221 0.3×	766 1.3×	40	5.5k

Countries citing papers authored by Julian Leathart

Since Specialization

Citations

This map shows the geographic impact of Julian Leathart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Leathart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Leathart more than expected).

Fields of papers citing papers by Julian Leathart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian Leathart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Leathart. The network helps show where Julian Leathart may publish in the future.

Co-authorship network of co-authors of Julian Leathart

This figure shows the co-authorship network connecting the top 25 collaborators of Julian Leathart. A scholar is included among the top collaborators of Julian Leathart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Leathart. Julian Leathart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aravinthan, Aloysious, George Mells, Michael Allison, et al.. (2014). Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease. Cell Cycle. 13(9). 1489–1494. 51 indexed citations

Yl, Liu, Gillian Patman, Julian Leathart, et al.. (2014). Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Journal of Hepatology. 61(1). 75–81. 404 indexed citations breakdown →

Özhan, Gül, Rajiv Lochan, Julian Leathart, Richard Charnley, & Ann K. Daly. (2011). Cyclooxygenase-2 Polymorphisms and Pancreatic Cancer Susceptibility. Pancreas. 40(8). 1289–1294. 9 indexed citations

Howard, Rebecca, Julian Leathart, David J. French, et al.. (2011). Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes. Clinica Chimica Acta. 412(23-24). 2063–2069. 26 indexed citations

Al‐Serri, Ahmad, Quentin M. Anstee, Luca Valenti, et al.. (2011). The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies. Journal of Hepatology. 56(2). 448–454. 139 indexed citations

Dongiovanni, Paola, Luca Valenti, Raffaela Rametta, et al.. (2010). Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut. 59(2). 267–273. 143 indexed citations

Day, Chris, Julian Leathart, Philip G. McTernan, Christopher G. Mathew, & Ann K. Daly. (2006). Genetic evidence for a role for gut flora in the pathogenesis of NASH in humans. Hepatology. 44(4). 8 indexed citations

Niemi, Mikko, Janne T. Backman, Lauri Kajosaari, et al.. (2005). Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clinical Pharmacology & Therapeutics. 77(6). 468–478. 287 indexed citations

Saksena, Seema, et al.. (2003). Manganese dependent superoxide dismutase (SOD2) targeting sequence polymorphism is associated with advanced fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 38. 22–23. 7 indexed citations

10.

King, Barry P., Julian Leathart, Elaine Mutch, Faith M. Williams, & Ann K. Daly. (2003). CYP3A5 phenotype‐genotype correlations in a British population. British Journal of Clinical Pharmacology. 55(6). 625–629. 63 indexed citations

11.

Mutch, Elaine, Ann K. Daly, Julian Leathart, Peter G. Blain, & Faith M. Williams. (2003). Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man?. Archives of Toxicology. 77(6). 313–320. 29 indexed citations

12.

Day, Chris, et al.. (2002). Genetic evidence supporting the two-hit model of NASH pathogenesis. Hepatology. 4 indexed citations

13.

Leathart, Julian, Elaine Mutch, Stuart Dunn, et al.. (2002). CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes. Biochemical Pharmacology. 64(11). 1579–1589. 197 indexed citations

14.

Stewart, Stephen, Julian Leathart, Ann K. Daly, et al.. (2002). Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology. 36(6). 1355–1360. 37 indexed citations

15.

Aithal, Guruprasad P., Christopher P. Day, Julian Leathart, & Ann K. Daly. (2000). Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis. Pharmacogenetics. 10(6). 511–518. 69 indexed citations

16.

Leathart, Julian, Stephanie J. London, Annette Steward, et al.. (1998). CYP2D6 phenotype ??? genotype relationships in African-Americans and Caucasians in Los Angeles. Pharmacogenetics. 8(6). 529–542. 85 indexed citations

17.

Leathart, Julian & David L. Gally. (1998). Regulation of type 1 fimbrial expression in uropathogenic Escherichia coli : heterogeneity of expression through sequence changes in the fim switch region. Molecular Microbiology. 28(2). 371–381. 32 indexed citations

18.

London, Stephanie J., Ann K. Daly, Julian Leathart, William Navidi, & Jeffrey R. Idle. (1996). Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics. 6(6). 527–533. 76 indexed citations

19.

Gally, David L., Julian Leathart, & Ian C. Blomfield. (1996). Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K‐12. Molecular Microbiology. 21(4). 725–738. 139 indexed citations

20.

Idle, Jeffrey R., Martin Armstrong, Alan V. Boddy, et al.. (1992). The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics. 2(6). 246–258. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact